Laboratory Features and Pathology of Cytokine Storm Syndromes

Flavia G Rosado1, Purva Gopal2

  • 1Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Insights

Diagnosing cytokine storm syndromes (CSSs), like hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), is difficult. This review covers CSS pathogenesis, lab findings, and diagnostic approaches for better clinical management.

Area of Science:

  • Immunology
  • Hematology
  • Clinical Pathology

Background:

  • Cytokine storm syndromes (CSSs), including hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), pose significant diagnostic challenges in clinical practice.
  • Routinely available laboratory tests for CSS diagnosis often lack specificity, complicating early and accurate identification.
  • The underlying disease mechanisms of CSSs, especially in adult populations, remain incompletely understood.

Purpose of the Study:

  • To review the pathogenesis of cytokine storm syndromes (CSSs).
  • To detail the laboratory findings associated with CSSs.
  • To outline recommended diagnostic strategies for CSSs, addressing current limitations.

Main Methods:

  • Literature review focusing on pathogenesis, laboratory diagnostics, and clinical management of CSSs.
  • Synthesis of information on hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS).
  • Analysis of diagnostic criteria and laboratory test utility for CSS detection.

Main Results:

  • Laboratory diagnosis of CSSs is challenging due to non-specific findings with standard tests.
  • Confirmatory diagnostic testing for CSSs is not widely accessible in many regions, including the United States.
  • Understanding of CSS pathogenesis, particularly in adults, is still evolving.

Conclusions:

  • Effective laboratory diagnosis of CSSs requires a comprehensive approach, integrating clinical and evolving laboratory data.
  • Improved diagnostic strategies are needed to overcome the limitations of current laboratory tests for CSSs.
  • Further research into CSS pathogenesis is crucial for developing more specific diagnostic markers and targeted therapies.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
966
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
923